Effectiveness of RSV-IVIG in premature infants: success in the home.
Hayes
C
C
Wilkerson
S
S
Bibb
K
K
Schuschke
L
L
Guest
A
A
D003362:Cost-Benefit Analysis; D018575:Home Care Services, Hospital-Based; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D007629:Kentucky; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses
D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous